Cervical cancer

HYPOfractionated RadioTherapy in Cervical Cancer

Who can joinWomen

Age18–65 years

Kind of studyStudy of how care is given

What it testsRadiation

The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.

Where to go

1 hospital in India taking patients for this trial.

National Cancer Institute, All India Institute of Medical Sciences, New Delhi, IndiaNew Delhi, New DelhiDirections ↗

Registry summary (technical)

The study is a prospective, randomized, non-inferiority clinical trial which will test whether a short course of radiation treatment (hypofractionation) for cervical cancer works as well as the standard longer course. Cervical cancer is one of the most common cancers in women in India, and many patients have trouble completing treatment because it takes several weeks and requires many hospital visits. In this trial, females with locally advanced cervical cancer will be randomly assigned to one of two treatment groups. One group will receive the standard radiation schedule with External Beam R…

Sponsor: All India Institute of Medical Sciences
NCT07625943 on ClinicalTrials.gov · CTRI number CTRI/2026/01/101615
Last updated on the registry 16 Jun 2026 · read by us 20 Oct 2026

Cervical cancer

Where to go

Need help reaching the trial team? Write to us.